Catalyst Pharmaceuticals Stock News

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 150 points on Monday. The Dow traded up 0.46% to 33,527.51 while the NASDAQ rose 1.55% to 11,313.03. Th

Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares climbed 444.4% to $1.47 after the company announced it successfully completed the review of results from Milestone 7, a phase of its biose

Announced Earlier Today-Notice Received from ANDA Filer for FIRDAPSE®

Catalyst (CPRX) could produce exceptional returns because of its solid growth attributes.

U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 30 points on Monday. The Dow traded up 0.94% to 33,687.69 while the NASDAQ rose 1.93% to 11,355.16. The S&P 500 a

U.S. stocks traded higher, with the Dow Jones gaining over 300 points on Monday. Here are some big stocks recording losses in today’s session. Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) shares

U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining around 90 points on Monday. Following the market opening Monday, the Dow traded up 0.11% to 33,411.62 while the NASDAQ

Catalyst (CPRX) could produce exceptional returns because of its solid growth attributes.

Zacks.com users have recently been watching Catalyst (CPRX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Holding on to popular or trending stocks for the long-term can make your portfolio a winner.

CORAL GABLES, Fla., Jan. 23, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (NASDAQ: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, an

Zacks.com users have recently been watching Catalyst (CPRX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Catalyst Pharmaceutical (CPRX) closed the most recent trading day at $20.27, moving -0.78% from the previous trading session.

Analysts have provided the following ratings for Catalyst Pharmaceuticals (NASDAQ:CPRX) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 3

XBI, Catalyst Pharma, Prometheus Biosciences, Sage Therapeutics and IBB are part of the Zacks Investment Ideas article.